Analyst consensus rating
Vicore Pharma Holding Analyst Rating: Strong Buy
Direct answer
Vicore Pharma Holding's consensus rating is Strong Buy.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $29.89.
Forecast evidence checked October 27, 2026.
Get free Vicore Pharma Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.35
- Average price target
- $29.89
- High price target
- $34.87
- Low price target
- $24.91
- Low target gap
- +166.4%
- Target upside
- +219.7%
- High target gap
- +272.9%
- Target range width
- 106.6%
- Consensus rating
- Strong Buy
- Analysts
- 2
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vicore Pharma Holding?
Vicore Pharma Holding has a verified Strong Buy consensus. The same dataset has an average price target of $29.89.
How far are Vicore Pharma Holding's low and high targets from the recorded price?
The low target implies +166.4%, while the high target implies +272.9%.
How many analysts are included in Vicore Pharma Holding's consensus?
The verified consensus includes 2 analysts.
How is Vicore Pharma Holding's target upside or downside calculated?
The average target of $29.89 is divided by the recorded price of $9.35, then one is subtracted to produce +219.7%. This does not guarantee a future return.
When was Vicore Pharma Holding's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.